Topic: Lung cancer.
Destination: Project funding grant with a partner clinical trial, focused on the development of novel therapies, including immunotherapeutic approaches, for patients with lung tumors harboring ALK translocations.
Budget: €2M.
Duration: 3 years.
Fill out the form below to receive more information:
